Search results
Tematy dnia
The European Medicines Agency's news announcements, information on meetings and events, public consultations and related information.
- What's new - European Medicines Agency (EMA)
What’s new. Find all new and updated information published...
- News | European Medicines Agency (EMA)
4 October 2024. Human Medicines Pharmacovigilance Referrals....
- What's new - European Medicines Agency (EMA)
4 October 2024. Human Medicines Pharmacovigilance Referrals. Improving efficiency of approval process for new medicines in the EU. Measures to optimise use of the EU's expert resources for faster assessments. 2 October 2024. EMA recommends suspension of sickle cell disease medicine Oxbryta.
What’s new. Find all new and updated information published on our website in one place below. Filters are available to narrow results down based on your interests, such as whether it relates to human or veterinary medicines or specific topics. This overview covers up to two months back. Current month Previous month Two months ago.
29 lis 2021 · MEPs will quiz EMA Executive Director Emer Cooke on the latest developments regarding COVID-19 vaccines and therapeutics in the EU. On Tuesday, Emer Cooke, Executive Director of the European Medicines Agency (EMA) will update Members of the Environment, Public Health and Food Safety (ENVI) Committee on the situation around COVID-19 vaccines ...
30 lis 2021 · Emer Cooke, Executive Director of the European Medicines Agency (EMA) reassured MEPs that the EMA is prepared to deal with the current challenges posed by the pandemic. Existing vaccines have remained effective until now, with studies showing that an additional dose or booster ensures extended immunity, she added.
30 lis 2021 · Health MEPs quizzed the EMA’s Executive Director on Tuesday on the current situation around COVID-19 vaccines and therapeutics, as well as the Agency’s future role.
4 kwi 2024 · Greater transparency between regulators and manufacturers can foster a better understanding of supply chain vulnerabilities and reduce risks of drug shortages, European Medicines Agency (EMA ...
